
About
BioInvent is a clinical-stage company that discovers and develops antibody drugs for cancer therapy. It also has a contract manufacturing business unit with in-house GMP facilities for producing drug substance for clinical trials. The company is based in Sweden and works with clients and partners in Europe, the USA, Japan and Australia.
Services
Antibody discovery and development
Discovers and develops antibodies for cancer therapy using its F.I.R.S.T™ screening platform and n-CoDeR® antibody library.
Clinical-stage antibody programs
Advances multiple clinical programs, including BI-1808, BI-1206 and BT-001, in oncology indications.
Contract manufacturing
Manufactures drug substance for clinical trials through BioInvent Manufacturing, its contract manufacturing business unit.
Capabilities
- Assays and studies
- Antibodies
- Screening
- Scale and capacity
- GMP facilities in-house
- Therapeutic areas
- Cancer
- Immuno-oncology
- T-cell lymphoma
- Solid tumors
- Non-Hodgkin lymphoma
Modalities and species
- Modalities
- Antibody
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
Industries served
- Oncology
Details
- Type
- CRDMO
- Founded
- 1988
- Based in
- Lund, Sweden
- Serves
- Europe, USA, Japan, Australia